| 摘要 |
Disclosed a modified and detoxified anticholinergic neurotoxic peptide that can suppress and prevent the onset of a T-cell mediated autoimmune reaction. The invention has application to the treatment of certain human autoimmune diseases, including especially multiple sclerosis, myasthenia gravis, and rheumatoid arthritis. More specifically, the method of treatment of autoimmune disorders is to administer a disease mitigating amount of a detoxified and neurotropically active modified alpha-neurotoxin composition.
|
